Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Updated on: September 27,2024

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Updated on:September 27,2024

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli

Updated on: December 20,2023

Routine HPV testing may be warranted for sinonasal cancers

(HealthDay)—Only one in four patients with sinonasal squamous cell carcinoma (SNSCC) is tested for human papillomavirus (HPV), according to a study published online Dec. 30 inCancer.Jamie R. Oli

Updated on:December 20,2023

Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainAccording to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies tha

Updated on: December 21,2023

Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainAccording to a research letter published inJAMA Internal Medicine, prostate cancer screening frequently results in biopsies tha

Updated on:December 21,2023

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on: August 27,2024

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on:August 27,2024

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Updated on: December 20,2023

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Updated on:December 20,2023

Earth's simplest and smallest animals rocket into space for cancer research

byLa Trobe UniversityCredit: La Trobe UniversityThe mission was to test the effects of zero gravity on Trichoplax, the tiny animals traveling to more than 250 km above the Earth, whose ancient m

Updated on: December 20,2023

Earth's simplest and smallest animals rocket into space for cancer research

byLa Trobe UniversityCredit: La Trobe UniversityThe mission was to test the effects of zero gravity on Trichoplax, the tiny animals traveling to more than 250 km above the Earth, whose ancient m

Updated on:December 20,2023

Scientists unlock potential for a small cell lung cancer blood test

by Mike Addelman,University of ManchesterMethylation score predicts survival in patients with SCLC. a, Kaplan–Meier curves showing OS of the 78 patients with SCLC stratified by high and low meth

Updated on: December 27,2023

Scientists unlock potential for a small cell lung cancer blood test

by Mike Addelman,University of ManchesterMethylation score predicts survival in patients with SCLC. a, Kaplan–Meier curves showing OS of the 78 patients with SCLC stratified by high and low meth

Updated on:December 27,2023

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Updated on: December 20,2023

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Updated on:December 20,2023

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

December 2023Leah LawrencePatients with previously untreated acute myeloid leukemia (AML) who were not candidates for intensive chemotherapy experienced disease response when treated with a combinatio

Updated on: February 18,2024

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

December 2023Leah LawrencePatients with previously untreated acute myeloid leukemia (AML) who were not candidates for intensive chemotherapy experienced disease response when treated with a combinatio

Updated on:February 18,2024

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Updated on: December 22,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Updated on:December 22,2023

Combination drug therapy shows promise for a treatment-resistant cancer

by Johns Hopkins University School of MedicineChristine Pratilas, M.D., in the lab. Credit: Frederick W. Dubs, Johns Hopkins Pathology Photography & GraphicsA combination of two cancer drugs

Updated on: May 21,2024

Combination drug therapy shows promise for a treatment-resistant cancer

by Johns Hopkins University School of MedicineChristine Pratilas, M.D., in the lab. Credit: Frederick W. Dubs, Johns Hopkins Pathology Photography & GraphicsA combination of two cancer drugs

Updated on:May 21,2024

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on: December 27,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on:December 27,2023